Document is current

Any future updates will be listed below

Correction: Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N-truncted Abeta in sporadic Alzheimer disease cases and mouse models

Crossref DOI link: https://doi.org/10.1007/s00401-024-02718-w

Published Online: 2024-03-25

Published Print: 2024-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark